性行為感染症の治療と診断

INTRODUCTION

The objective of the study is to present a comprehensive look at sexually transmitted diseases. Markets are divided according to diseases. Several of the products are used in multiple markets. The report is directed to decision-makers in the various areas of sexually transmitted disease markets to present insight into those arenas for current and future development.

REASONS FOR STUDY

This BCC study is presented to heighten the awareness of sexually transmitted diseases, their cause, and identify pharmaceutical preparations, devices and important advancements affecting markets within the sexually transmitted disease market. The study analyzes the new therapeutics and diagnostics for sexually transmitted diseases and it addresses issues and trends affecting the market. Manufacturers of pharmaceutical products, devices and test kits for sexually transmitted diseases have stepped up discovery, as the engine driving growth in all markets is research and development. Because of the evolving nature of the many areas of sexually transmitted diseases, executives involved in specific STD markets must remain ever vigilant of the changing environment and strive to keep abreast of current and potential opportunities.

SCOPE OF STUDY

The report is designed to be a comprehensive business tool to provide an in-depth look at sexually transmitted diseases. The geographic scope of the report is the United States. The report identifies common sexually transmitted diseases; gives a brief explanation of the disease; cites risk factors, incidence and mortality; presents current treatments, and market size and participants. The report describes the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.

New Therapeutics and Diagnostics for Sexually Transmitted Diseases is divided into categories by type of disease as follows:

• Bacterial Vaginosis
• Candidiasis
• Chancroid
• Chlamydia
• Genital Herpes
• Genital Warts
• Gonorrhea
• Hepatitis B
• HIV/AIDS
• Pediculosis Pubis
• Syphilis
• Trichomoniasis

Each segment is discussed in detail, describing the disease, risk factors, incidence and mortality, identifying current products on the market in the base year 2000, measuring current and potential market size, identifying current and potential market drivers, forecasting for 2005, assessing current and potential competitors, and identifying current competitor market shares.

METHODOLOGY AND INFORMATION SOURCES

The information and analysis presented in this BCC report are based on extensive first hand interviews with primary executives, product managers, and clinical specialists in the areas of sexually transmitted diseases. Background information was obtained from various government, business, medical journal and trade magazines and interviews with doctors and nurses. Key information from published literature was used to conduct interviews with over 92 industry participants to validate and obtain expert opinions on current and future trends in sexually transmitted diseases. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.

All market data pertain to the U.S. market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year is 2000. Historical data are provided for 1998 and 1999 and forecast data are provided for 2005. Historical, base year and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2000 base year.

ANALYST CREDENTIALS

Mary Anne Crandall is an RN/Instructor/Medical Analyst specializing in the pharmaceuticals industry.

RELATED BCC REPOPTS

• C-050U Advanced Drug Delivery Systems: New Developments, New Technologies
• B-130 The Expanding Market For Psychotherapeutic Drugs
• B-144 Apoptosis: New Growth Opportunities
• B-146 Pain Management
• B-114R Protein Drugs: Manufacturing Technologies
• DDTN Drug Discovery/Technology News (a monthly newsletter)
• AGN Applied Genetics News

• INTRODUCTION
• REASONS FOR STUDY
• SCOPE OF STUDY
• METHODLOGY AND INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC REPORTS
• EXECUTIVE SUMMARY
• INDUSTRY OVERVIEW
• DEFINITION OF SEXUALLY TRANSMITTED DISEASES
• EPIDEMIOLOGY AND ETIOLOGY OF SEXUALLY TRANSMITTED DISEASES
• PREVALENCE
  • HEALTH AND ECONOMIC CONSEQUENCES OF SEXUALLY TRANSMITTED DISEASES
  • TRENDS IN STDS
  • CLINICAL GUIDELINES FOR SEXUALLY TRANSMITTED DISEASES
  • PREVENTION OF SEXUALLY TRANSMITTED DISEASES
  • PREGNANCY AND SEXUALLY TRANSMITTED DISEASES
  • REGULATORY AND LEGISLATIVE ACTIONS FOR SEXUALLY TRANSMITTED DISEASES
  • CURRENT AND FUTURE NEEDS
• BACTERIAL VAGINOSIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR BACTERIAL VAGINOSIS
  • TREATMENTS FOR BACTERIAL VAGINOSIS
  • MARKET SIZE AND GROWTH FOR BACTERIAL VAGINOSIS
  • RESEARCH AND DEVELOPMENT FOR BACTERIAL VAGINOSIS
  • MARKET ANALYSIS
• CANDIDIASIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CANDIDIASIS
  • TREATMENTS FOR CANDIDIASIS
  • MARKET SIZE AND GROWTH FOR CANDIDIASIS
  • RESEARCH AND DEVELOPMENT FOR CANDIDIASIS
  • MARKET ANALYSIS
• CHANCROID (VENERAL ULCERS)
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CHANCROID
  • TREATMENTS FOR CHANCROID
  • MARKET SIZE AND GROWTH FOR CHANCROID
  • RESEARCH AND DEVELOPMENT IN CHANCROID
  • MARKET ANALYSIS
• CHLAMYDIA
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CHLAMYDIA
  • TREATMENTS FOR CHLAMYDIA
  • MARKET SIZE AND GROWTH FOR CHLAMYDIA
  • RESEARCH AND DEVELOPMENT FOR CHLAMYDIA
  • MARKET ANALYSIS
• GENITAL HERPES
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR GENITAL HERPES
  • TREATMENTS FOR GENITAL HERPES
  • MARKET SIZE AND GROWTH FOR GENITAL HERPES
  • RESEARCH AND DEVELOPMENT FOR GENITAL HERPES
  • MARKET ANALYSIS
• GENITAL WARTS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOTIC TREATMENT FOR GENITAL WARTS
  • TREATMENTS FOR GENITAL WARTS
  • MARKET SIZE AND GROWTH FOR GENITAL WARTS
  • RESEARCH AND DEVELOPMENT FOR GENITAL WARTS
  • MARKET ANALYSIS
• GONORRHEA
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR GONORRHEA
  • TREATMENTS FOR GONORRHEA
  • MARKET SIZE AND GROWTH FOR GONORRHEA
  • RESEARCH AND DEVELOPMENT FOR GONORRHEA
  • MARKET ANALYSIS
• HEPATITIS B
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR HEPATITIS B
  • TREATMENTS FOR HEPATITIS B
  • MARKET SIZE AND GROWTH FOR HEPATITIS B
  • RESEARCH AND DEVELOPMENT FOR HEPATITIS B
  • MARKET ANALYSIS
• HIV/AIDS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR HIV.AIDS
  • TREATMENTS FOR HIV/AIDS
  • MARKET SIZE AND GROWTH FOR HIV/AIDS
  • RESEARCH AND DEVELOPMENT FOR HIV/AIDS
  • MARKET ANALYSIS
• PEDICULOSIS PUBIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR PEDICULOSIS PUBIS
  • TREATMENTS FOR PEDICULOSIS PUBIS
  • MARKET SIZE AND GROWTH FOR PEDICULOSIS PUBIS
  • RESEARCH AND DEVELOPMENT FOR PEDICULOSIS PUBIS
  • MARKET ANALYSIS
• SYPHILIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTICS FOR SYPHILIS
  • TREATMENTS FOR SYPHILIS
  • MARKET SIZE AND GROWTH FOR SYPHILIS
  • RESEARCH AND DEVELOPMENT FOR SYPHILIS
  • MARKET ANALYSIS
• TRICHOMONIASIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR TRICHOMONIASIS
  • TREATMENTS FOR TRICHOMONIASIS
  • MARKET SIZE AND GROWTH FOR TRICHOMONIASIS
  • RESEARCH AND DEVELOPMENT FOR TRICHOMONIASIS
  • MARKET ANALYSIS
• THE OVERALL MARKET
• INTRODUCTION
  • TOTAL MARKET FOR THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES
  • MARKET PERCENTAGE BY PRODUCT TYPE AND MARKET SEGMENT
  • INDUSTRY PARTICIPANTS BY PRODUCT TYPE
• COMPANY PROFILES
• NEW THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES - PHARMACEUTICAL MANUFACTURERS
  • 3M PHARMACEUTICALS
  • ABBOTT LABORATORIES
  • BOEHRINGER INGELHEIM CORPORATION
  • BRISTOL-MYERS SQUIBB COMPANY
  • GLAXO WELLCOME, INC.
  • MERCK & COMPANY, INC.
  • NOVARTIS PHARMACEUTICAL CORPORATION
  • PHARMACIA CORPORATION
  • PFIZER, INC.
  • ROCHE LABORATORIES
  • SMITHKLINE BEECHAM PHARMACEUTICALS
• NEW THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES  EMERGING PHARMACEUTICAL MANUFACTURERS
  • AVANIR PHARMACEUTICALS
  • BIOSYN, INC.
  • CANTAB PHARMACEUTICALS PLC
  • GILEAD SCIENCES, INC.
  • THE MEDICINES COMPANY
  • MEDIMMUNE, INC.
  • TRIANGLE PHARMACEUTICALS, INC.
  • VERTEX PHARMACEUTICALS
• APPENDIX: CURRENT PHARMACEUTICAL MANUFACTURERS, NAMES AND ADDRESSES

LIST OF TABLES

• SUMMARY TABLE:
  MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005

1. CAUSATIVE ORGANISM FOR SEXUALLY TRANSMITTED DISEASES
2. U.S. POPULATION BY AGE, 1990-2005
3. U.S. LIFE EXPECTANCY BY RACE AND SEX, 1990-1999
4. U.S. PREGNANT WOMEN WITH STDs, 1999
5. BACTERIAL VAGINOSIS U.S. INCIDENCE RATES, 1990-2005
6. MARKET SIZE OF U.S. BACTERIAL VAGINOSIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
7. BACTERIAL VAGINOSIS PRODUCTS IN DEVELOPMENT
8. BACTERIAL VAGINOSIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
9. CANDIDIASIS U.S. INCIDENCE RATES 1990-2005
10. MARKET SIZE OF U.S. CANDIDIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
11. CANDIDIASIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
12. CHANCROID (VENERAL ULCERS) U.S. INCIDENCE RATES, 1990-2005
13. MARKET SIZE OF U.S. CHANCROID (VENERIAL ULCER) PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
14. CHANCROID (VENERAL ULCERS) PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
15. CHLAMYDIA U.S. INCIDENCE RATES BY SEX, 1990-2005
16. CHLAMYDIA U.S. INCIDENCE RATES BY REGION, 1990-2005
17. MARKET SIZE OF U.S. CHLAMYDIA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
18. CHLAMYDIA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
19. GENITAL HERPES SIMPLEX VIRUS INFECTIONS U.S. INCIDENCE RATES BY SEX, 1990-2005
20. MARKET SIZE OF U.S. GENITAL HERPES PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
21. GENITAL HERPES PRODUCTS IN DEVELOPMENT
22. GENITAL HERPES PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
23. GENITAL WARTS U.S. INCIDENCE RATES BY SEX, 1990-2005
24. MARKET SIZE OF U.S. GENITAL WART PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
25. GENITAL WART PRODUCTS IN DEVELOPMENT
26. GENITAL WARTS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
27. GONORRHEA U.S. INCIDENCE RATES BY SEX, 1990-2005
28. GONORRHEA U.S. INCIDENCE RATES BY REGION, 1990-2005
29. MARKET SIZE OF U.S. GONORRHEA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
30. DRUGS IN DEVELOPMENT FOR GONORRHEA
31. GONORRHEA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
32. HEPATITIS B INFECTION (SEXUALLY TRANSMITTED) U.S. INCIDENCE FOR BOTH SEXES, ALL AGES, ALL RACES, 1990-2005
33. MARKET SIZE OF U.S. HEPATITIS B PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
34. PR0DUCTS IN DEVELOPMENT FOR HBV
35. HEPATITIS B PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
36. MODES OF HIV TRANSMISSION
37. CDC CLASSIFICATION OF HIV INFECTION
38. HIV/AIDS U.S. INCIDENCE RATES BY SEX, AGE, AND RACE, 1990-2005
39. HIV/AIDS U.S. INCIDENCE BY SEX AND TRANSMISSION CATEGORY FOR BOTH SEXES, ALL AGES, AND ALL RACES, 1990-2005
40. U.S. AIDS DEATHS BY RACE, 1990-2000
41. HIV LIFE CYCLE
42. MARKET SIZE OF U.S. HIV/AIDS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
43. DRUGS IN DEVELOPMENT FOR HIV/AIDS
44. HIV/AIDS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
45. PEDICULOSIS PUBIS U.S. INCIDENCE RATES, 1990-2005
46. MARKET SIZE OF U.S. PEDICULOSIS PUBIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
47. PEDICULOSIS PUBIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
48. STAGES OF SYPHILIS
49. SYPHILIS U.S. INCIDENCE RATES BY SEX, 1990-2005
50. SYPHILIS U.S. INCIDENCE RATES BY REGION, 1990-2005
51. MARKET SIZE OF U.S. SYPHILIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
52. SYPHILIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
53. TRICHOMONIASIS U.S. INCIDENCE RATES, 1990-2005
54. MARKET SIZE OF U.S. TRICHOMONIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
55. TRICHOMONIASIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
56. MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
57. PERCENTAGE OF MANUFACTURERS BY MARKET SEGMENT, 2000
58. SELECTED INDUSTRY PARTICIPANTS BY PRODUCT TYPE

LIST OF FIGURES

• SUMMARY FIGURE:
  MARKET SHARE BY MARKET SEGMENT, 1998-2005

1. BACTERIAL VAGINOSIS U.S. INCIDENCE RATES, 1990-2005
2. MARKET SIZE OF U.S. BACTERIAL VAGINOSIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
3. BACTERIAL VAGINOSIS PRODUCT MANUFACTURER MARKET SHARE, 2000
4. CANDIDIASIS INCIDENCE RATES, 1990-2005
5. MARKET SIZE OF U.S. CANDIDIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
6. CANDIDIASIS PRODUCT MANUFACTURER MARKET SHARE, 2000
7. CHANCROID (VENERAL ULCERS) U.S. INCIDENCE RATES, 1990-2005
8. MARKET SIZE OF U.S. CHANCROID (VENERAL ULCERS) PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
9. CHANCROID (VENERAL ULCERS) PRODUCT MANUFACTURER MARKET SHARE, 2000
10. CHLAMYDIA U.S. INCIDENCE RATES BY SEX, 1990-2005
11. CHLAMYDIA U.S. INCIDENCE RATES BY REGION, 1990-2005
12. MARKET SIZE OF U.S. CHLAMYDIA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
13. CHLAMYDIA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
14. GENITAL HERPES SIMPLEX VIRUS INFECTIONS U.S. INCIDENCE RATES BY SEX, 1990-2005
15. MARKET SIZE OF U.S. GENITAL HERPES PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
16. GENITAL HERPES PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
17. GENITAL WARTS U.S. INCIDENCE RATES BY SEX, 1990-2005
18. MARKET SIZE OF U.S. GENITAL WART PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
19. GONORRHEA U.S. INCIDENCE RATES BY SEX, 1990-2005
20. GONORRHEA U.S. INCIDENCE RATES BY REGION, 1990-2005
21. MARKET SIZE OF U.S. GONORRHEA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
22. GONORRHEA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
23. HEPATITIS B INFECTION (SEXUALLY TRANSMITTED) U.S. INCIDENCE FOR BOTH SEXES, ALL AGES, ALL RACES, 1990-2005
24. MARKET SIZE OF U.S. HEPATITIS B PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
25. HEPATITIS B PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
26. U.S. AIDS DEATHS BY RACE, 1990-2000
27. MARKET SIZE OF U.S. HIV/AIDS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
28. HIV/AIDS PRODUCT MANUFACTURER MARKET SHARE, 2000
29. PEDICULOSIS PUBIS U.S. INCIDENCE RATES, 1990-2005
30. MARKET SIZE OF U.S. PEDICULOSIS PUBIS PRODUCTSAT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
31. PEDICULOSIS PUBIS PRODUCT MANUFACTURER MARKET SHARE, 2000
32. SYPHILIS U.S. INCIDENCE RATES BY SEX, 1990-2005
33. SYPHILIS U.S. INCIDENCE RATES BY REGION, 1990-2005
34. MARKET SIZE OF U.S. SYPHILIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
35. SYPHILIS PRODUCT MANUFACTURER MARKET SHARE, 2000
36. TRICHOMONIASIS U.S. INCIDENCE RATES, 1990-2005
37. MARKET SIZE OF U.S. TRICHOMONIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
38. TRICHOMONIASIS PRODUCT MANUFACTURER MARKET SHARE, 2000
39. MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S MANUFACTURERS - SALES LEVELS, 1998-2005
40. NUMBER OF SELECTED MANUFACTURERS SUPPLYING MARKET SEGMENTS, 2000
41. MARKET SHARE BY MARKET SEGMENT, 2000